Cancer Clinical Trial
— PAPRIKAOfficial title:
PAPRIKA - Patients Empowerment for Major Surgery Preparation @Home
PAPRIKA establishes a technologically enabled and personalized prehabilitation and follow-up
after surgical intervention program for patients undergoing elective major surgery Program
creates close collaboration between the medical environment and the patients empowering them
to co-create their own care.
It is at the first stage aimed to high-risk patients undergoing major surgery. Better
condition before the surgery is proved to reduce the perioperative complications and to
improve patients' health-related quality of life while cutting the associated costs. The
concept integrates short-term (average 4 weeks) preoperative interventions including
endurance training, promotion of physical activity and nutritional and psychological support.
Interventions are planned both at community and at hospital reducing unnecessary interactions
between patients and tertiary care.
PAPRIKA tackles three major drivers: i) human perspective ii) organizational challenges and
iii) technical aspects. The project is based on previous experience on prehabilitation and
the already refined service using design thinking methodologies. It will be also based on the
proven reduction of associated costs for the healthcare system.
Status | Recruiting |
Enrollment | 300 |
Est. completion date | July 30, 2020 |
Est. primary completion date | June 30, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - Age > 70 years old and/or American Society of Anesthesiologist (ASA) index 3-4 and/or highly aggressive surgery or solid organ transplantation. Exclusion Criteria: - Non-elective surgery; metastatic disease. |
Country | Name | City | State |
---|---|---|---|
Spain | Hospital Clínic de Barcelona | Barcelona | Catalonia |
Lead Sponsor | Collaborator |
---|---|
Hospital Clinic of Barcelona |
Spain,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Six-minute walk test | Distance covered during the six-minute walk test | At program inclusion and at program discharge (on average at 6 weeks) | |
Other | Physical activity | Physical activity measured by the Yale Physical Activity Survey (YPAS) (range 0 to 142; the lowest the worst) | At program inclusion and at program discharge (on average at 6 weeks) | |
Other | Psycho-emotional status | Psycho-emotional status measured by the Hospital Anxiety and Depression (HAD) scale (range 0-21; the highest the worst) | At program inclusion and at program discharge (on average at 6 weeks) | |
Primary | Postoperative complications | Number of postoperative complications during the initial hospitalization for surgery | Duration of the initial hospitalization for surgery | |
Primary | Hospital length of stay | Number of days of hospital length of stay during the initial hospitalization for surgery | Duration of the initial hospitalization for surgery | |
Primary | Severity of postoperative complications | Severity of postoperative complications during the initial hospitalization for surgery using the Clavien-Dindo classification | Duration of the initial hospitalization for surgery | |
Secondary | Hospital readmissions at 30 days | Number of postoperative complications during a 30-day period after surgery | From initial hospital discharge to 30 days follow-up | |
Secondary | Emergency room visits at 30 days | Number of emergency room visits during a 30-day period after surgery | From initial hospital discharge to 30 days follow-up | |
Secondary | Surgical reinterventions at 30 days | Number of surgical reinterventions during a 30-day period after surgery | From initial hospital discharge to 30 days follow-up | |
Secondary | Mortality at 30 days | Number of exitus during a 30-day period after surgery | From initial hospital discharge to 30 days follow-up |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
Completed |
NCT04448041 -
CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
|
||
Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|